Concise reports
Chondroitin sulphation patterns in synovial fluid in osteoarthritis subsets
Samantha Lewisa, Margot Crossmana, Joanne Flannellyc, Carolyn Belcherb, Michael Dohertyb, Michael T Baylissc, Roger M Masona
a Molecular
Pathology Section, Division of Biomedical Sciences, Imperial College
School of Medicine, South Kensington, London SW7 2AZ, b Rheumatology Unit, City Hospital, Nottingham, c Department
of Veterinary Basic Sciences, The Royal Veterinary College, London
Correspondence to: Professor R M Mason.
Accepted for publication 26 March 1999
| |
Abstract |
|---|
|
|
|---|
OBJECTIVES
To
determine concentrations of chondroitin sulphate (CS) disaccharides in
knee synovial fluid (SF) from normal subjects and patients with
osteoarthritis (OA) or rheumatoid arthritis (RA), to test whether these
variables differ between different diseases and subsets of OA.
METHODS
OA was
subdivided into large joint OA (LJOA), nodal generalised OA (NGOA), and
OA with calcium pyrophosphate crystal deposition (CPA), with 25, 9, and
11 people in each subset respectively. The SF of 13 normal subjects was
also volunteered for analysis along with 15 RA patients. Clinical
assessment of inflammation (0-6) was undertaken on OA and RA knees.
Concentrations of unsaturated CS disaccharides
di6S and
di4S were
measured by capillary zone electrophoresis.
RESULTS
Concentrations
of
di6S were lower in RA (5.90 ng/ml) and OA (13.24 ng/ml) fluids
compared with normal (21.0 ng/ml) but no significant differences were
seen between disease and normal fluids for
di4S (about 4-6 ng/ml).
The ratio of
di6S:
di4S were RA<OA<normal subjects (p<0.001 for
all comparisons). The disaccharide concentration values along with the
ratios are below. Higher
di6S:
di4S ratios were obtained for LJOA
and CPA compared with NGOA. Uninflamed knees had lower concentrations
of
di6S than inflamed knees (p<0.01). In patients with bilateral
samples, there were strong correlations between right and left knees
for all SF variables.
CONCLUSIONS
Altered
ratios of CS sulphation patterns occur in OA and within OA subsets.
These further justify considering NGOA as a subset with a different aetiopathogenesis.
(Ann Rheum Dis 1999;58:441-445)
| |
Introduction |
|---|
|
|
|---|
Glycosaminoglycans have been used to measure both
anabolic and catabolic events in diseased joints. Thus, the expression
of specific sulphation epitopes on chondroitin sulphate (CS) chains, recognised by monoclonal antibodies 3B3 and 7D4, have been linked to
the biosyntheses of abnormal proteoglycans in pathological joint
tissues.1 2 In contrast, measurements of total sulphated glycosaminoglycan and the keratan sulphate epitope
5D4,3 and more recent work with aggrecan CS epitope
8464 are generally accepted as indicators of connective
tissue degradation. Changes in chondroitin sulphation were also
exploited by Shinmei et al5 in
an attempt to differentiate between catabolic processes in inflammatory
and non-inflammatory arthritis. This was achieved by analysing the
relative proportion of the unsaturated chondroitin sulphate
disaccharides
di6S and
di4S released into synovial fluid
after digesting CS with chondroitin lyase ABC. A more recent study
extended this preliminary investigation and, by analysing the
disaccharide content of normal synovial fluids as well as those from
patients with joint disease, showed that the sulphation pattern was
age, sex and disease related.6
In this study we have taken this approach a step further, to determine whether the concentration of unsaturated disaccharides in synovial fluid could also be used to differentiate between patients with different subsets of osteoarthritis (OA). OA is a heterogeneous condition and a number of subsets with possible differing pathogenesis have been suggested. We wish to determine whether there are biochemical differences between these subsets at the same effective site (the knee).
| |
Methods |
|---|
|
|
|---|
PATIENTS AND CLINICAL ASSESSMENT
Local research ethics committee approval was obtained for the
study. Hospital referred patients with symptomatic knees affected by
OA or rheumatoid arthritis (RA) were studied. Patients with knee
OA all had radiographic evidence of joint space narrowing and
osteophyte in one or more knee compartments (medial or lateral tibiofemoral, patellofemoral). Other joint pathology was excluded on
the basis of full clinical assessment, radiographic features, synovial
fluid (SF) examination and serological and biochemical tests.7 The RA patients all fulfilled ACR criteria for
definite RA and all had symptoms and signs of knee involvement by RA.
Radiological scoring was undertaken on subjects where SF was obtained
within six months of an available radiograph, using the system
previously described.7 For each of the three compartments,
a score was given for narrowing (0-3) and osteophyte (0-3); summated
scores for each knee were calculated for each feature (0-9). There was significant variation in the volume of SF aspirated from indivdual people, this variation was corrected for in the final calculations.
The knee OA patients were subdivided into three subsets as previously.8
Pauciarticular large joint OA (LJOA)
Knee OA with or without OA of other large joints (hips/shoulders),
but no Heberden's nodes or clinical/radiographic evidence of
polyarticular hand interphalangeal OA.
Nodal generalised OA (NGOA)
Knee OA, plus Heberden's (with or without Bouchard's) nodes and
radiographic evidence of interphalangeal OA (narrowing and/or osteophyte) affecting two or more rays of each hand.
Chronic pyrophosphate arthropathy (CPA)
Knee OA with calcium pyrophosphate dihydrate crystals identified
in their knee SF (with or without radiographic chondrocalcinosis). Crystal identification was by compensated polarised light microscopy of
fresh synovial fluid. Patients that overlapped these groups, for
example those with NGOA and calcium pyrophosphate dihydrate crystals,
were not included in the study.
SYNOVIAL FLUIDS
Knees were aspirated to apparent dryness via a medial approach. A
small sample of fresh SF was examined for crystals and the remainder
collected into sterile plastic containers on ice, centrifuged at 2500 g for 15 minutes at 4°C and the
supernatant stored at
80°C.
UNSATURATED CS DISACCHARIDES
DI6S
AND
DI4S
Synovial fluids were sequentially digested with streptomyces
hyaluronidase and chondroitin ABC lyase and the resultant unsaturated chondroitin disaccharides were analysed by capillary zone
electrophoresis.10
STATISTICAL ANALYSIS
Comparison between disease groups was by Friedman two way analysis
of variance and the Mann-Whitney U test with a Bonferroni correction.
Correlations were calculated using Spearman's correlation coefficient.
| |
Results |
|---|
|
|
|---|
DEMOGRAPHIC DETAILS
Table 1 shows the subject numbers, ages and male:female
ratios.Although the average age of the control group was younger than
either of the OA or RA groups (p<0.05), the age range of all OA groups
were similar. There were no significant differences between all OA
groups for radiographic scores (osteophyte, joint space narrowing and
radiograph total).
|
DISACCHARIDE ANALYSIS
Correlation between left and right knees
In patients where data were available on both knee joint SF, there
were significant correlations between right and left joints for
di6S,
di4S or
di6S:
di4S ratio
(r=0.69-0.86, p<0.001). Consequently, one
knee was chosen at random for use in data analysis.
Comparison of RA, OA, and normal groups
There were distinct differences in the concentrations of the
individual unsaturated disaccharides and in their ratios, between the
control and patient groups and also within the patient groups. The
concentration of
di6S was significantly lower in the RA SF than in
the fluids from either OA patients (p<0.001) or normal knee joints
(p<0.001) and it was also significantly lower in OA fluids compared
with the normal controls (p<0.001) (fig 1). In marked contrast, there
were no significant differences in the
di4S concentration of the
control and disease groups. Thus, the ratios of
di6S:
di4S were
significantly different when diseased fluids were compared with normal
controls; RA < OA < control (p<0.001 for all comparisons).
|
Comparison of OA subgroups
There were no differences between the OA subgroups in the
concentration of
di6S or
di4S (fig 2). However, significantly higher
di6S:
di4S ratios were obtained for the LJOA and the CPA groups when compared with the NGOA group (p<0.05 in each case).
|
Comparison of OA (active) and OA (inactive)
In OA knee joints scored as having active inflammation, there was
a significantly lower concentration of
di6S (p<0.05) than in
inactive knee joints. The numbers of active and inactive in each OA
subgroup were too small for statistical analysis.
Correlation of sulphation data with clinical scores for all OA
groups combined
There were no significant correlations between sulphation data and
radiographic scores.
Correlation of sulphation parameters with age in normal SF
There was no significant correlation of any of the disaccharide
values measured with the age of the person.
| |
Discussion |
|---|
|
|
|---|
Joint tissues, particularly articular cartilage, undergo various degrees of structural degeneration in OA and RA. There is also published evidence indicating that the metabolism of extracellular matrix components (collagen, proteoglycans and non-collagenous matrix proteins) is severely affected by the disease process and that products of this abnormal turnover are released into the SF.11 This physiological mechanism has provided the impetus for a number of studies investigating the mechanism(s) of tissue injury in joint disease. Using chemical and immunological methods to measure specific molecular fragments, temporal changes in various anabolic and catabolic pathways have been investigated. This approach has enabled novel hypotheses to be formulated concerning connective tissue repair and degeneration in arthritis. The objective of this study was not to identify a "marker" of a particular type of arthritic disease, but to investigate whether specific chondroitin sulphation patterns were associated with altered connective tissue metabolism when patients with classic OA of large joints had additional clinical and/or biochemical features associated with their joint disease.
The finding that the sum of chondroitin disaccharide (
di6S +
di4S) concentrations in OA and RA joint fluids was significantly lower than those in normal fluids, suggests that the total mass of
articular cartilage was decreased in the arthritic patients. These
results are consistent with a study by Saxne et
al,12 who found that there was an inverse
correlation between cartilage destruction and the concentration of
proteoglycan in SF. Similarly, the decreased ratio of
di6S:
di4S
measured in the OA and RA fluids supported the analyses of Shinmei
et al5 and Sharif
et al.6 However, the major new
finding reported here is that the
di6S:
di4S ratio is
significantly lower in patients who have nodal OA of the hand in
addition to knee OA, compared with those who only have large joint
OA
that is, they have a synovial fluid composition that is more akin
to that measured in RA SF. Although this suggests that similar
biological mechanisms may be involved when nodal OA is present, it is
worth noting that the presence of clinical inflammation in the OA
groups did not affect the disaccharide values; the presence of
pyrophosphate crystals, a known inflammatory mediator, in the SF did
not affect the analyses. Furthermore, the significant correlation
between the left and right knee joints for their SF analyses, as
previously reported for SF hyaluronan, glycosaminoglycans, CS, keratan
sulphate and pyrophosphate,8 13 suggest that these SF
measures reflect an aspect of the patient rather than the local state
of the joint. This is the second report of biochemical difference that
has been detected in subsets of OA at the same anatomical
site8 and is further justification for considering NGOA as
a subset with a possibly different aetiopathogenesis.
Although the changes in SF composition have been discussed as if only articular cartilage were involved, the contribution of extra-articular tissues such as the meniscus, cruciate ligament and synovium to the SF pool should not be underestimated.14 These tissues also have CS containing proteoglycans in their extracellular matrix and their relative turnover in joint tissues is not known. However, in all arthritic joints soft tissues also show degenerative changes and the extent of these may contribute, in part, to the subgroup specific, SF composition.
This investigation demonstrates that disaccharide measurements of SF can provide useful information about the metabolic status of joint tissues and this analytical technique will be used in future studies to determine how temporal changes in joint disease and the effect of pharmaceutical intervention changes fluid composition.
| |
Footnotes |
|---|
Funding: we would like to thank the Arthritis Research Campaign, and The Oliver Bird Fund for Rheumatism for their generous financial support.
| |
References |
|---|
|
|
|---|
| 1. | Caterson B, Griffin J, Mahmoodian F, Sorrell JM. Monoclonal antibodies against chondroitin sulphate isomers: their use as probes for investigating proteoglycan metabolism. Biochem Soc Trans 1990;18:820-823[Medline]. |
| 2. | Hazell PK, Dent C, Fairclough JA, Bayliss MT, Hardingham TE. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 1995;38:953-959[Medline]. |
| 3. | Thonar EJ, Masuda K, Hauselmann HJ, Uebelhart D, Lenz ME, Manicourt DH. Keratan sulfate in body fluids in joint disease. Acta Orthop Scand Suppl 1995;266:103-106[Medline]. |
| 4. |
Lundberg C,
Asberg I,
Ionescu M,
Reiner A,
Smedegard G,
Poole AR. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
Ann Rheum Dis
1996;55:525-534 |
| 5. | Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulphate and chondroitin 6-sulphate in pathological joint fluid. Arthritis Rheum 1992;35:1304-1308[Medline]. |
| 6. |
Sharif M,
Osborne DJ,
Meadows K,
Woodhouse SM,
Colvin EM,
Shepstone L,
et al. The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid.
Br J Rheumatol
1996;35:951-957 |
| 7. |
Ledingham JM,
Regan M,
Jones A,
Doherty M. Radiographic patterns and associations of knee osteoarthritis in a hospital referred population.
Ann Rheum Dis
1993;52:520-526 |
| 8. |
Doherty M,
Richards N,
Hornby J,
Powell R. Relationship between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis and crystal associated arthropathy.
Ann Rheum Dis
1988;47:190-197 |
| 9. |
Jones A,
Hopkinson N,
Pattrick M,
Berman P,
Doherty M. Evaluation of a method for clinically assessing osteoarthritis of the knee.
Ann Rheum Dis
1992;51:243-245 |
| 10. | Gaffen JD, Gleave S, Crossman MV, Bayliss MT, Mason RM. Articular cartilage proteoglycans in osteoarthritic STR/ort mice. Osteoarthritis Cartilage. 1995;3:95-104[Medline]. |
| 11. | Heinegard D, Saxne T. Molecular markers of processes in cartilage in joint disease. Br J Rheumatol 1991;30:21-24. |
| 12. | Saxne T, Wollheim FA, Pettersson H, Heinegard D. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis? BMJ 1987;295:1447-1448 . |
| 13. |
Doherty M,
Belcher C,
Regan M,
Jones A,
Ledingham J. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of osteoarthritis.
Ann Rheum Dis
1996;55:432-436 |
| 14. | Bayliss MT, Davidson C, Woodhouse SM, Osborne DJ. Chondroitin sulphation in human joint tissues varies with age, zone and topography. Acta Orthop Scand 1995;66:22-25. |
© 1999 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Pothacharoen, P., Kalayanamitra, K., Deepa, S. S., Fukui, S., Hattori, T., Fukushima, N., Hardingham, T., Kongtawelert, P., Sugahara, K.
(2007). Two Related but Distinct Chondroitin Sulfate Mimetope Octasaccharide Sequences Recognized by Monoclonal Antibody WF6. J. Biol. Chem.
282: 35232-35246
[Abstract] [Full Text] -
Bautch, J. C, Clayton, M. K, Chu, Q., Johnson, K. A
(2000). Synovial fluid chondroitin sulphate epitopes 3B3 and 7D4, and glycosaminoglycan in human knee osteoarthritis after exercise. Ann Rheum Dis
59: 887-891
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.


